[SYRS] YoY Quarter Result on 30-Sep-2017 [#Q3]

Stock
[SYRS] Syros Pharmaceuticals, Inc.
Announcement Date
08-Nov-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- -3.42%
YoY- 2.43%
Quarter Report
SYRS's Result
SYRS's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
Revenue 5,697 3,828 558 412 0 0 0 -
PBT -26,027 -19,486 -19,793 -15,737 -13,825 -14,169 -8,464 20.56%
Tax 984 0 0 0 0 0 0 -
NP -26,027 -19,486 -19,793 -15,737 -13,825 -14,169 -8,464 20.56%
Tax Rate - - - - - - - -
Total Cost 31,724 23,314 20,351 16,149 13,825 14,169 8,464 24.60%
Ratio Analysis
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
NP Margin -456.85 -509.04 -3,547.13 -3,819.66 0.00 0.00 0.00 -
Per Share
30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 CAGR
EPS -4.14 -4.26 -4.66 -4.68 -5.26 -6.44 -33.15 -29.27%
EPS Diluted -4.14 -4.26 -4.66 -4.68 -5.26 -6.44 -33.15 -29.27%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.